Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
The Long Run with Luke Timmerman
00:00
The Appeal of Being Part of a Sustainable Platform Company
This chapter discusses the speaker's journey to their current company, Belhara, and the importance of true platform nature in small molecule drug discovery. They provide examples of companies with successful platform approaches.
Transcript
Play full episode
